Smoking Cessation

Matthew A. Steliga, MD, spoke with Healio about a presentation on smoking cessation programs for patients being screened for lung cancer given at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

In this video, Matthew A. Steliga, MD, highlights presentations in tobacco cessation given at this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Pfizer has voluntarily expanded its recall of Chantix 0.5 mg and 1 mg tablets because of the presence of the nitrosamine N-nitroso-varenicline at or above the FDA interim acceptable intake limit.

The American Thoracic Society Tobacco Action Committee released a new policy with recommendations created to reduce tobacco use, and increase research, treatment and tobacco treatment program implementation.

Patients with COPD who received care in an accredited advanced COPD center of excellence clinic had lower ED use compared with those who received care at another center, researchers reported.

Current smokers with early-stage lung cancer who quit smoking after their diagnosis had improved overall and progression-free survival rates, according to a prospective cohort study.

Concomitant targeting of smoking cessation and drinking reduction via pharmacotherapy appeared feasible, according to results of a randomized clinical trial published in American Journal of Psychiatry.

More than one-fourth of adults with CVD use tobacco products and few of them quit over 5 years, researchers reported.

In this video, Alayna P. Tackett, PhD, discusses new research on respiratory symptoms of e-cigarette use in adolescents and young adults.

Despite historic lows in smoking prevalence, rates of cancer prevention and early detection remained suboptimal in the U.S. between 2018 and 2019, according to a study by researchers at American Cancer Society.